DPP4 and type 2 diabetes mellitus: Vildagliptin is a selective inhibitor of DPP-4, which works efficiently in enhancing glycemic control in patients with T2DM by increasing insulin secretion, decreasing glucagon secretion, slowing down gastric emptying, and enhancing pancreatic islet function [9].